Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Chondroitinase ABC is a promising preclinical therapy that promotes functional neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery of chondroitinase ABC to the injured mammalian spinal cord can be achieved by viral vector transgene delivery. This approach dramatically modulates injury pathology and restores sensorimotor functions. However, clinical development of this therapy is limited by a lack of ability to exert control over chondroitinase gene expression. Prior experimental gene regulation platforms are likely to be incompatible with the non-resolving adaptive immune response known to occur following spinal cord injury. Therefore, here we apply a novel immune-evasive dual vector system, in which the chondroitinase gene is under a doxycycline inducible regulatory switch, utilizing a chimeric transactivator designed to evade T cell recognition. Using this novel vector system, we demonstrate tight temporal control of chondroitinase ABC gene expression, effectively removing treatment upon removal of doxycycline. This enables a comparison of short and long-term gene therapy paradigms in the treatment of clinically-relevant cervical level contusion injuries in adult rats. We reveal that transient treatment (2.5 weeks) is sufficient to promote improvement in sensory axon conduction and ladder walking performance. However, in tasks requiring skilled reaching and grasping, only long term treatment (8 weeks) leads to significantly improved function, with rats able to accurately grasp and retrieve sugar pellets. The late emergence of skilled hand function indicates enhanced neuroplasticity and connectivity and correlates with increased density of vGlut1+ innervation in spinal cord grey matter, particularly in lamina III-IV above and below the injury. Thus, our novel gene therapy system provides an experimental tool to study temporal effects of extracellular matrix digestion as well as an encouraging step towards generating a safer chondroitinase gene therapy strategy, longer term administration of which increases neuroplasticity and recovery of descending motor control. This preclinical study could have a significant impact for tetraplegic individuals, for whom recovery of hand function is an important determinant of independence, and supports the ongoing development of chondroitinase gene therapy towards clinical application for the treatment of spinal cord injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 2×
“Lentiviral vectors (second generation) were generated as described previously (Naldini et al., 1996; Hendriks et al., 2007).”
MethodAhuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings, M. G. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.18 · Cited by 2,441
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381 · cited 1×
“neurodegenerative diseases (Mendell et al., 2017), where any”
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 1×
“, 2011) and promotes functional recovery following spinal cord injury in adult rats (Bradbury et al., 2002; Garcia-Alias et al., 2009).”
BackgroundSelf-citationTargeting Recovery: Priorities of the Spinal Cord-Injured Population
Anderson, K. D. (2004) · Journal of Neurotrauma · doi:10.1089/neu.2004.21.1371 · Cited by 2,094 · cited 1×
“…Spinal Cord Statistical Centre, 2017) and a top priority for improving independence and quality of life is recovery of hand and digit function (Anderson, 2004), we investigate the effect of dox-i-ChABC treatment following a clinically relevant cervical spinal contusion injury model in adult…”
BackgroundReactivation of Ocular Dominance Plasticity in the Adult Visual Cortex
Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J. W., & Maffei, L. (2002) · Science · doi:10.1126/science.1072699 · Cited by 1,679
McKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130192197 · Cited by 928
The cellular inflammatory response in human spinal cords after injury
Fleming, J. C., Norenberg, M. D., Ramsay, D. A., Dekaban, G. A., Marcillo, A. E., Saenz, A. D., Pasquale-Styles, M., Dietrich, W. D., & Weaver, L. C. (2006) · Brain · doi:10.1093/brain/awl296 · Cited by 847
Perineuronal Nets Protect Fear Memories from Erasure
Gogolla, N., Caroni, P., Lüthi, A., & Herry, C. (2009) · Science · doi:10.1126/science.1174146 · Cited by 760 · cited 1×
“effectively reopen the critical period and re-enable induction of ocular dominance plasticity and the erasure of subsequently acquired fear memories (Pizzorusso et al., 2002; Gogolla et al., 2009).”
BackgroundHematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy
Eichler, F., Duncan, C., Musolino, P. L., Orchard, P. J., De Oliveira, S., Thrasher, A. J., Armant, M., Dansereau, C., Lund, T. C., Miller, W. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700554 · Cited by 604 · cited 1×
“However, recent success with lentiviral-mediated gene therapy for the treatment of cerebral adrenoleukodystrophy in children (Eichler et al., 2017) also highlights the ongoing potential of lentivirus-based systems for clinical use.”
BackgroundChondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord Injury
Barritt, A. W., Davies, M., Marchand, F., Hartley, R., Grist, J., Yip, P., McMahon, S. B., & Bradbury, E. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2980-06.2006 · Cited by 413 · cited 4×
“ChABC enzyme (Barritt et al., 2006; Karimi-Abdolrezaee et al., 2010; Alilain et al., 2011) and with non-regulated ChABC gene therapy (Bartus et al.”
BackgroundMethodSelf-citationAsynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke
Wahl, A. S., Omlor, W., Rubio, J. C., Chen, J. L., Zheng, H., Schröter, A., Gullo, M., Weinmann, O., Kobayashi, K., Helmchen, F., et al. (2014) · Science · doi:10.1126/science.1253050 · Cited by 322 · cited 1×
“…interventions such as antiNogo immunotherapy where sequential (rather than concurrent) timing of the neuroplasticity intervention and the rehabilitation protocol was shown to improve recovery from experimental stroke and spinal cord injury (Wahl et al., 2014; Chen et al., 2017).”
BackgroundImproved Tet-responsive promoters with minimized background expression
Loew, R., Heinz, N., Hampf, M., Bujard, H., & Gossen, M. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-81 · Cited by 246
Optimization of the Tet-On system for regulated gene expression through viral evolution
Zhou, X., Vink, M., Klaver, B., Berkhout, B., & Das, A. T. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302780 · Cited by 224 · cited 1×
“have been optimized for use in vitro (Urlinger et al., 2000; Zhou et al., 2006; Loew et al., 2010) and have shown promise in some in vivo experiments (Stieger et al.”
MethodViral vectors for therapy of neurologic diseases
Choudhury, S. R., Hudry, E., Maguire, C. A., Sena-Esteves, M., Breakefield, X. O., & Grandi, P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.013 · Cited by 190 · cited 1×
“, 2012) and in the CNS, AAVs are the most commonly used vector in clinical trials targeting tumours and neuronal disorders (Choudhury et al., 2017).”
BackgroundGene therapy for lipoprotein lipase deficiency
Gaudet, D., Méthot, J., & Kastelein, J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283555a7e · Cited by 178 · cited 1×
“AAV-based gene therapy has been approved for clinical use in the treatment of genetic lipoprotein lipase deficiency (Gaudet et al., 2012) and in the CNS, AAVs are the most commonly used vector in clinical trials targeting tumours and neuronal disorders (Choudhury et al.”
MethodFavre, D., Blouin, V., Provost, N., Spisek, R., Porrot, F., Bohl, D., Marmé, F., Chérel, Y., Salvetti, A., Hurtrel, B., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11605-11611.2002 · Cited by 150
Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology
Yang, S., Cacquevel, M., Saksida, L. M., Bussey, T. J., Schneider, B. L., Aebischer, P., Melani, R., Pizzorusso, T., Fawcett, J. W., & Spillantini, M. G. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.11.013 · Cited by 138
Latta-Mahieu, M., Rolland, M., Caillet, C., Wang, M., Kennel, P., Mahfouz, I., Loquet, I., Dedieu, J.-F., Mahfoudi, A., Trannoy, E., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201707 · Cited by 114
Ginhoux, F., Turbant, S., Gross, D. A., Poupiot, J., Marais, T., Lone, Y., Lemonnier, F. A., Firat, H., Perez, N., Danos, O., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.012 · Cited by 49
Markusic, D. M., de Waart, D. R., & Seppen, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009974 · Cited by 22 · cited 1×
“, 2016), observed following gene delivery to the peripheral nervous system in rats (Markusic et al., 2010) and primates (Favre et al.”
Background
Cited by
Moving beyond the glial scar for spinal cord repair
Bradbury, E. J., & Burnside, E. R. (2019) · Nature Communications · doi:10.1038/s41467-019-11707-7 · Cited by 743
Self-citationThe translational landscape in spinal cord injury: focus on neuroplasticity and regeneration
Hutson, T. H., & Di Giovanni, S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0280-3 · Cited by 302
Cerebellar plasticity and associative memories are controlled by perineuronal nets
Carulli, D., Broersen, R., de Winter, F., Muir, E. M., Mešković, M., de Waal, M., de Vries, S., Boele, H.-J., Canto, C. B., De Zeeuw, C. I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916163117 · Cited by 110
Self-citationRehabilitation enhances epothilone-induced locomotor recovery after spinal cord injury
Griffin, J. M., Hingorani Jai Prakash, S., Bockemühl, T., Benner, J. M., Schaffran, B., Moreno-Manzano, V., Büschges, A., & Bradke, F. (2022) · Brain Communications · doi:10.1093/braincomms/fcad005 · Cited by 19
“Previous work suggests that microtubule stabilization combined and rehabilitation may be both therapeutic avenues with translational potential for SCI.24–26,30,50 Here, we tested their combinatorial potential and found that systemic epoB administration followed by rehabilitation-enhanced functional recovery.”
BackgroundInfluentialAnderson, M. D., Paylor, J. W., Scott, G. A., Greba, Q., Winship, I. R., & Howland, J. G. (2020) · Learning & Memory · doi:10.1101/lm.050245.119 · Cited by 16
Metadata
- Authors
- Burnside, E. R., De Winter, F., Didangelos, A., James, N. D., Andreica, E.-C., Layard-Horsfall, H., Muir, E. M., Verhaagen, J., & Bradbury, E. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-14
- Volume
- 141
- Issue
- 8
- Pages
- 2362-2381
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2884540135
- Cited by
- 111
- References
- 22
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.